ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 38 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 42.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $54,285 | -40.3% | 150,794 | -0.1% | 0.00% | – |
| Q3 2022 | $91,000 | -28.3% | 150,983 | -40.8% | 0.00% | – |
| Q2 2022 | $127,000 | -71.6% | 254,950 | -48.7% | 0.00% | – |
| Q1 2022 | $447,000 | +59.1% | 496,972 | +98.1% | 0.00% | – |
| Q4 2021 | $281,000 | -34.0% | 250,819 | +4.7% | 0.00% | – |
| Q3 2021 | $426,000 | -44.2% | 239,508 | +3.5% | 0.00% | – |
| Q2 2021 | $764,000 | +416.2% | 231,459 | +425.3% | 0.00% | – |
| Q1 2021 | $148,000 | 0.0% | 44,066 | -45.8% | 0.00% | – |
| Q4 2020 | $148,000 | +4833.3% | 81,277 | +4189.0% | 0.00% | – |
| Q3 2020 | $3,000 | -83.3% | 1,895 | -79.8% | 0.00% | – |
| Q2 2020 | $18,000 | +38.5% | 9,396 | -27.0% | 0.00% | – |
| Q1 2020 | $13,000 | -64.9% | 12,879 | -30.7% | 0.00% | – |
| Q4 2019 | $37,000 | – | 18,582 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,270,758 | $2,262,000 | 0.72% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $4,476,000 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 975,305 | $1,736,000 | 0.36% |
| DAFNA Capital Management LLC | 732,500 | $1,304,000 | 0.35% |
| KNOTT DAVID M | 478,186 | $851,000 | 0.31% |
| Vivo Capital, LLC | 2,840,909 | $5,057,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 688,400 | $1,225,000 | 0.17% |
| MYDA Advisors LLC | 236,165 | $420,000 | 0.12% |
| Affinity Asset Advisors, LLC | 250,000 | $445,000 | 0.11% |
| RTW INVESTMENTS, LP | 3,250,000 | $5,785,000 | 0.09% |